Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h

MAS-<i>like</i> is associated with poorer responses, reduced PFS and OS, especially in patients meeting all UCSF criteria. High tumour burden, including elevated monoclonal component, high ISS and extramedullary disease, seems to contribute to MAS-<i>like</i> development.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-10-16
DOI
https://doi.org/10.3389/fimmu.2025.1654096
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h

Juan Luis Reguera, Sara Varea, Álvaro Urbano-Ispizúa, Julio Delgado et al.
Frontiers in Immunology
Autoimmune and Inflammatory Disorders Research
article

Macrophage activation syndrome-like in multiple myeloma patients treated with the academic CAR-T against BCMA ARI0002h

Juan Luis Reguera, Sara Varea, Álvaro Urbano-Ispizúa, Julio Delgado, Cristina Arnaldos‐Perez, Luis Gerardo Rodríguez‐Lobato, María‐Victoria Mateos, Joaquín Martínez‐López, Natalia Tovar, Elena Guillén, Carlos Fernández de Larrea, Verónica González‐Calle, Aina Oliver‐Caldés, Lucía López‐Corral, Nieves López‐Muñoz, Valentín Cabañas, Europa Azucena González‐Navarro, Juan Carlos Ponce, José M. Moraleda, Núria Martínez‐Cibrián, Paula Rodríguez‐Otero, Daniel Munárriz, Ana África Martín
article en

Abstract

MAS-<i>like</i> is associated with poorer responses, reduced PFS and OS, especially in patients meeting all UCSF criteria. High tumour burden, including elevated monoclonal component, high ISS and extramedullary disease, seems to contribute to MAS-<i>like</i> development.

Frontiers in ImmunologyVol. 16
Research Institute Hospital 12 de Octubre (ES), Navarre Institute of Health Research (ES), Instituto de Biomedicina de Sevilla (ES), Centro de Investigación del Cáncer (ES), Instituto Murciano de Investigación Biosanitaria (ES), Centro de Investigación Biomédica en Red de Cáncer (ES), Consorci Institut D'Investigacions Biomediques August Pi I Sunyer (ES)
“la Caixa” Foundation, European Commission, Generalitat de Catalunya, Universidad de Navarra, CRIS Cancer Foundation, Agència de Gestió d'Ajuts Universitaris i de Recerca, Instituto de Salud Carlos III, European Regional Development Fund
Openalex Percentile: Top 63%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.